Open Beta
TREN
MetriLume
TREN

US marketsNEUP

SEC-sourced researchBeta

NEUP

Neuphoria Therapeutics Inc.

Company comparison ↗

Data passport

CIK
0001191070
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: June 2025: 15,649,448.0000 USD; June 2026: 1,174,165.0000 USD15.6M USD0 USD0June 2025June 2026
NEUP · Exact amounts and source periods · USD
Period endRevenueFiling date
June 202515,649,448.0000Sep 18, 2026
June 20261,174,165.0000Sep 18, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
June 20261,174,165.0000-13,451,931.0000-12,353,074.000028,709,016.00004,108,994.0000Sep 18, 2026
June 202515,649,448.0000-369,632.000077,229.000028,589,614.00009,587,040.0000Sep 18, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.17MJune 2026Sep 18, 202610-K
Previous period revenueRevenues$15.65MJune 2025Sep 18, 202610-K
Net incomeNetIncomeLoss-$13.45MJune 2026Sep 18, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$12.35MJune 2026Sep 18, 202610-K
Total assetsAssets$28.71MJune 2026Sep 18, 202610-K
Total liabilitiesLiabilities$4.11MJune 2026Sep 18, 202610-K

New filings

Explore methodology ↗